Based on the reduced expression of EP4 in normal kidney tissue compared to RCC cells and the potential role of EP4 but not EP2 in malignancy aggressiveness, EP4 may be a safer and more effective target in RCC patients. Here, PTGER4 is linked to renal cell carcinoma.